These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23097067)
61. Fluid REStriction in Heart Failure vs Liberal Fluid UPtake: Rationale and Design of the Randomized FRESH-UP Study. Herrmann JJ; Beckers-Wesche F; Baltussen LEHJM; Verdijk MHI; Bellersen L; Brunner-la Rocca HP; Jaarsma T; Pisters R; Sanders-van Wijk S; Rodwell L; Van Royen N; Gommans DHF; Van Kimmenade RRJ J Card Fail; 2022 Oct; 28(10):1522-1530. PubMed ID: 35705150 [TBL] [Abstract][Full Text] [Related]
62. Sildenafil in heart failure with reactive pulmonary hypertension (Sildenafil HF) clinical trial (rationale and design). Guglin M; Rajagopalan N; Anaya P; Charnigo R Pulm Circ; 2016 Jun; 6(2):161-7. PubMed ID: 27252841 [TBL] [Abstract][Full Text] [Related]
63. Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction. Reddy YN; Borlaug BA Eur J Heart Fail; 2017 Jan; 19(1):126-128. PubMed ID: 27873389 [No Abstract] [Full Text] [Related]
64. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E; JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662 [TBL] [Abstract][Full Text] [Related]
65. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials. Zhuang XD; Long M; Li F; Hu X; Liao XX; Du ZM Int J Cardiol; 2014 Apr; 172(3):581-7. PubMed ID: 24534379 [TBL] [Abstract][Full Text] [Related]
66. Sustained improvement of clinical status and pulmonary hypertension in patients with severe heart failure treated with sildenafil. Urbanowicz T; Straburzyńska-Migaj E; Katyńska I; Araszkiewicz A; Oko-Sarnowska Z; Grajek S; Jemielity M Ann Transplant; 2014 Jul; 19():325-30. PubMed ID: 25007352 [TBL] [Abstract][Full Text] [Related]
67. Macitentan in pulmonary hypertension due to left ventricular dysfunction. Vachiéry JL; Delcroix M; Al-Hiti H; Efficace M; Hutyra M; Lack G; Papadakis K; Rubin LJ Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29437943 [TBL] [Abstract][Full Text] [Related]
68. The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension. Chowdhury B; Luu AZ; Luu VZ; Kabir MG; Pan Y; Teoh H; Quan A; Sabongui S; Al-Omran M; Bhatt DL; Mazer CD; Connelly KA; Verma S; Hess DA Biochem Biophys Res Commun; 2020 Mar; 524(1):50-56. PubMed ID: 31980166 [TBL] [Abstract][Full Text] [Related]
69. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. Bermejo J; Yotti R; García-Orta R; Sánchez-Fernández PL; Castaño M; Segovia-Cubero J; Escribano-Subías P; San Román JA; Borrás X; Alonso-Gómez A; Botas J; Crespo-Leiro MG; Velasco S; Bayés-Genís A; López A; Muñoz-Aguilera R; de Teresa E; González-Juanatey JR; Evangelista A; Mombiela T; González-Mansilla A; Elízaga J; Martín-Moreiras J; González-Santos JM; Moreno-Escobar E; Fernández-Avilés F; Eur Heart J; 2018 Apr; 39(15):1255-1264. PubMed ID: 29281101 [TBL] [Abstract][Full Text] [Related]
70. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial. Gheorghiade M; Greene SJ; Butler J; Filippatos G; Lam CS; Maggioni AP; Ponikowski P; Shah SJ; Solomon SD; Kraigher-Krainer E; Samano ET; Müller K; Roessig L; Pieske B; JAMA; 2015 Dec; 314(21):2251-62. PubMed ID: 26547357 [TBL] [Abstract][Full Text] [Related]
71. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M; Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816 [TBL] [Abstract][Full Text] [Related]